#Stem cell treatment of ms trial#

Stem cell treatments for MS have made substantial progress. In these cases, the patient’s immune system is dismantled through chemotherapy, before the immune system is re-started with their own HSCs – similar to how these same cells are used to treat cancers like leukemias. The other strategy being applied is to utilize hematopoietic stem cells (HSCs), which are commonly derived from cord blood.

#Stem cell treatment of ms trial#

Another study, funded by BrainStorm Cell Therapeutics, utilizes similar methods and is also in the advanced trial phase.

One such trial is funded by the National Multiple Sclerosis Society, focusing on the growth factors and immune-suppressing properties of MSCs. Mesenchymal stem cells (MSCs), which can be obtained in cord tissue or through Placental Tissue 2.0 TM, have been involved in numerous promising trials. Various stem cell treatments are in the advanced trial phase. RRMS is the most common, but all forms typically require a disease-modifying therapy.

There’s more than one type of MS.Īccording to the National Multiple Sclerosis Society, MS involves an immune-mediated process in which the body’s immune system attacks the central nervous system, causing inflammation that damages myelin, the substance that insulates nerve fibers. Stem cell treatments for the notoriously difficult to treat multiple sclerosis (MS) are frequently in the news, but as with all new medical treatments, the effectiveness and real potential of these trials is not always immediately evident.